tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

IMCR Stock Latest News

Immunocore Holdings Outlines Strategic Priorities for 2025
Company AnnouncementsImmunocore Holdings Outlines Strategic Priorities for 2025
8d ago
8K
IMCR
Immunocore reports cash, equivalents of $820M as of December 31
PremiumThe Fly
Immunocore reports cash, equivalents of $820M as of December 31
8d ago
IMCR
Immunocore announces 2025 strategic priorities at JPM Conference
PremiumThe Fly
Immunocore announces 2025 strategic priorities at JPM Conference
8d ago
IMCR
Immunocore Holdings Strengthens Leadership with Key Appointment
PremiumCompany Announcements
Immunocore Holdings Strengthens Leadership with Key Appointment
16d ago
8K
IMCR
Immunocore appoints Travis Coy as CFO and Head of Corporate Development
PremiumThe Fly
Immunocore appoints Travis Coy as CFO and Head of Corporate Development
16d ago
IMCR
Immunocore announces first patient dosed in Phase 1 trial of IMC-P115C
PremiumThe FlyImmunocore announces first patient dosed in Phase 1 trial of IMC-P115C
26d ago
IMCR
Immunocore announces treatment of first patient in Phase 1/2 trial of IMC-R117C
Premium
The Fly
Immunocore announces treatment of first patient in Phase 1/2 trial of IMC-R117C
1M ago
IMCR
Immunocore downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Immunocore downgraded to Equal Weight from Overweight at Morgan Stanley
1M ago
IMCR
Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial
PremiumThe Fly
Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial
1M ago
IMCR
Immunocore downgraded to Neutral from Outperform at Mizuho
PremiumThe Fly
Immunocore downgraded to Neutral from Outperform at Mizuho
2M ago
IMCR
Immunocore Holdings Prepares Early Loan Agreement Termination
PremiumCompany Announcements
Immunocore Holdings Prepares Early Loan Agreement Termination
2M ago
8K
IMCR
Immunocore Holdings Plc Reports Strong Q3 Revenue Growth
PremiumCompany Announcements
Immunocore Holdings Plc Reports Strong Q3 Revenue Growth
2M ago
IMCR
Immunocore reports Q3 EPS 17c, consensus (35c)
PremiumThe FlyImmunocore reports Q3 EPS 17c, consensus (35c)
2M ago
IMCR
Immunocore reports cash, equivalents of $901.3M as of September 30
Premium
The Fly
Immunocore reports cash, equivalents of $901.3M as of September 30
2M ago
IMCR
Immunocore initiated with a Sell at UBS
Premium
The Fly
Immunocore initiated with a Sell at UBS
3M ago
IMCR
Immunocore price target lowered to $74 from $80 at Morgan Stanley
PremiumThe Fly
Immunocore price target lowered to $74 from $80 at Morgan Stanley
3M ago
IMCR
Immunocore downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Immunocore downgraded to Neutral from Buy at Guggenheim
3M ago
IMCR
Immunocore downgraded at Guggenheim with trajectory for Kimmtrak appreciated
PremiumThe Fly
Immunocore downgraded at Guggenheim with trajectory for Kimmtrak appreciated
3M ago
IMCR
Immunocore presents Phase 1 data of brenetafusp in ovarian cancer
PremiumThe Fly
Immunocore presents Phase 1 data of brenetafusp in ovarian cancer
4M ago
IMCR
Immunocore CFO Brian Di Donato to depart
PremiumThe FlyImmunocore CFO Brian Di Donato to depart
5M ago
IMCR
Immunocore price target raised to $89 from $87 at Oppenheimer
Premium
The Fly
Immunocore price target raised to $89 from $87 at Oppenheimer
5M ago
IMCR
Immunocore price target lowered to $66 from $92 at Barclays
Premium
The Fly
Immunocore price target lowered to $66 from $92 at Barclays
5M ago
IMCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >